TTY Biopharm Company Limited (TPEX:4105)

Taiwan · Delayed Price · Currency is TWD

83.40

+0.20 (0.24%)

At close: Mar 5, 2026

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Adjustments and Eliminations	-	-	-268.62M	-274.72M	-231.74M
Healthcare Business Group	186.34M	195.63M	581.66M	221.48M	212.63M
Healthcare Business Group Growth	-4.75%	-66.37%	162.62%	4.16%	-19.72%
Other Department	35.23M	65.44M	106.64M	270.72M	196.05M
Other Department Growth	-46.16%	-38.64%	-60.61%	38.09%	895.68%
Reinvestment Segment	1.12B	814.45M	747.28M	-	-
Reinvestment Segment Growth	37.00%	8.99%	-	-	-
Cancer Drug Business Group	2.40B	2.43B	2.34B	2.77B	2.61B
Cancer Drug Business Group Growth	-1.21%	3.78%	-15.44%	6.18%	-13.82%
Export and OEM Group	936.49M	796.70M	653.68M	-	-
Export and OEM Group Growth	17.55%	21.88%	-	-	-
Anti-infection medicine segment	1.22B	1.20B	899.62M	1.14B	989.45M
Anti-infection medicine segment Growth	1.32%	33.77%	-20.80%	14.79%	25.78%
Cardiovascular and Gastrointestinal Drugs Business Group	-	-	-	413.48M	447.86M
Cardiovascular and Gastrointestinal Drugs Business Group Growth	-	-	-	-7.68%	-11.78%
Total	5.89B	5.51B	5.06B	4.54B	4.22B
Total Growth	7.05%	8.77%	11.60%	7.43%	-5.47%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Taiwan	5.12B	4.84B	4.60B	4.25B	3.93B
Taiwan Growth	5.78%	5.24%	8.33%	8.01%	5.49%
America	381.29M	265.71M	59.43M	-	-
America Growth	43.50%	347.07%	-	-	-
Other Countries	391.78M	398.66M	402.12M	289.25M	278.03M
Other Countries Growth	-1.73%	-0.86%	39.02%	4.04%	-13.19%
Europe	-	-	-	-	12.20M
Europe Growth	-	-	-	-	-97.09%
Total	5.89B	5.51B	5.06B	4.54B	4.22B
Total Growth	7.05%	8.77%	11.60%	7.43%	-5.47%

Source: S&P Global Market Intelligence.